Zymeworks (ZYME) Deferred Taxes (2021 - 2026)
Zymeworks (ZYME) reported Deferred Taxes of $2.2 million for Q1 2026, up 436.59% on a YoY basis from $410000.0 in Q1 2025, and up 256.03% sequentially from -$1.4 million in Q4 2025.
Zymeworks (ZYME) Deferred Taxes (2021 - 2026) Analysis & Trends
Zymeworks (ZYME) has 6 years of Deferred Taxes data on file, last reported at $2.2 million in Q1 2026.
- For the quarter ending Q1 2026, Deferred Taxes rose 436.59% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $845000.0 (up 364.89% YoY), and the FY2025 full-year result was -$945000.0, down 36.76% from the prior year.
- Deferred Taxes grew to $2.2 million in Q1 2026, from -$1.4 million in the prior quarter.
- In the past five years, Deferred Taxes ranged from a high of $2.2 million in Q1 2026 to a low of -$1.9 million in Q4 2022.
- A 5-year average of -$36411.8 and a median of $38000.0 in 2024 frame the typical range for Deferred Taxes.
- Across the five-year window, Deferred Taxes sank 249.76% in 2022 and soared 978.95% in 2025, its largest moves.
- Tracing ZYME's Deferred Taxes over 5 years: stood at -$1.9 million in 2022, then surged by 151.41% to $967000.0 in 2023, then plunged by 216.55% to -$1.1 million in 2024, then dropped by 25.11% to -$1.4 million in 2025, then jumped by 256.03% to $2.2 million in 2026.
- Business Quant data shows ZYME's Deferred Taxes at $2.2 million in Q1 2026, -$1.4 million in Q4 2025, and $170000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Deferred Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,741.39 Bn | 66,741.11 Bn | - | - |
| 2 | Nanobiotix | 1,913.26 Bn | 1,913.20 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.02 Bn | 466.23 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 122.17 Bn | 114.92 Bn | 2.59 Bn | -65.30 Mn |
| 6 | Regeneron Pharmaceuticals | 69.85 Bn | 61.10 Bn | 3.31 Bn | 96.00 Mn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.60 Bn | 50.42 Bn | 1.41 Bn | - |
| 9 | Alnylam Pharmaceuticals | 37.39 Bn | 34.38 Bn | 959.66 Mn | 9.31 Mn |
| 10 | Zymeworks | 1.73 Bn | 1.37 Bn | - | 2.20 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 2.20 Mn |
| Dec 31, 2025 | -1.41 Mn |
| Sep 30, 2025 | 170,000.00 |
| Jun 30, 2025 | -115,000.00 |
| Mar 31, 2025 | 410,000.00 |
| Dec 31, 2024 | -1.13 Mn |
| Sep 30, 2024 | 204,000.00 |
| Jun 30, 2024 | 194,000.00 |
| Mar 31, 2024 | 38,000.00 |
| Dec 31, 2023 | 967,000.00 |
| Sep 30, 2023 | -95,000.00 |
| Jun 30, 2023 | -106,000.00 |
| Mar 31, 2023 | -9,000.00 |
| Dec 31, 2022 | -1.88 Mn |
| Sep 30, 2022 | 411,000.00 |
| Jun 30, 2022 | 265,000.00 |
| Mar 31, 2022 | -735,000.00 |
| Dec 31, 2021 | 1.26 Mn |